Observational study / 2011
Higher intake of folate from foods was linked to a lower risk of esophageal adenocarcinoma in an Australian case-control study.
Researchers evaluated the relationship between dietary and supplemental intake of folate, B vitamins, and methyl-group donors and the risk of Barrett's esophagus (BE) and esophageal cancers in two Australian case-control studies. Increasing intake of food folate was associated with reduced EAC risk (P-trend = 0.01) and mitigated ESCC risks associated with smoking and alcohol. Conversely, high intake of folic acid from supplements was linked to a significantly elevated risk of BE with dysplasia, and supplemental thiamin, riboflavin, niacin, and B-12 were associated with higher EAC risk. High dietary riboflavin and methionine were linked to increased EAC risk, while dietary betaine was associated with lower risks of BE without (P-trend = 0.004) or with dysplasia (P-trend = 0.02).
Shows an association, not proof of cause and effect.
- Study type
- Two population-based case-control studies
- Who was studied
- 367 BE patients (266 without, 101 with dysplasia) vs 577 controls; 881 esophageal cancer patients (636 EAC, 245 ESCC) vs 1,507 controls in Australia
- What was measured
- Risk of Barrett's esophagus (with or without dysplasia), esophageal adenocarcinoma (EAC), and esophageal squamous cell carcinoma (ESCC)
THE PAPER
High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population.
Ibiebele TI, Hughes MC, Pandeya N, Zhao Z, Montgomery G, Hayward N, Green AC, Whiteman DC, Webb PM, Study of Digestive Health, Australian Cancer Study. J Nutr, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.